CELLINFECT

Where fermentation science meets skincare innovation

CELLINFECT was born from a breakthrough in Lactobacillus-derived exosome technology. By preserving the integrity of 100 billion exosomes through a patented extraction process, every product delivers active ingredients at a cellular level — far beyond what traditional formulations can achieve.

From the world-first PLLAcule compound (PLLA fused with natural spicules) to the EMS Rejuator device, CELLINFECT represents a new category of skincare where biotechnology and device innovation work in harmony.

Two breakthroughs. One brand.

Two proprietary technologies form the foundation of every CELLINFECT product — Lacto Exosome for cellular-level delivery and PLLAcule for collagen stimulation from within.

Each technology is backed by patents, published research and clinical testing.

• 100 billion intact exosomes — Patented extraction preserves exosome structure for maximum delivery efficiency
• PLLAcule 5,000ppm — World-first PLLA + spicule compound creates micro-channels for deep penetration
• Published in WILEY — Lacto Exosome research published in peer-reviewed international journal (Dec 2025)
• 15 efficacy tests completed — Including clinical trials on firmness, hydration and pore reduction